ERT, a provider of patient data collection solutions for use in clinical drug development, has named Joe Eazor as president and CEO. His appointment is effective October 5, 2020. Most recently, Eazor ...
Wolman’s disease, a severe form of lysosomal acid lipase deficiency, leads to pathologic lipid accumulation in the liver and gut that, without treatment, is fatal in infancy. Although continued enzyme ...
eResearchTechnology, Inc. (“ERT”), a leading global data and technology company which minimises risk and uncertainty in clinical trials, is pleased to announce an investment by Astorg, who will enter ...
PHILADELPHIA, April 14, 2011 /PRNewswire/ -- ERT (Nasdaq: ERT), a global technology-driven provider of clinical services and customizable medial devices to biopharmaceutical and healthcare ...
PHILADELPHIA, Feb. 15, 2012 /PRNewswire/ -- ERT (NASDAQ: ERT), a global technology-driven provider of health outcomes services and customizable medical devices to biopharmaceutical sponsors and ...
PHILADELPHIA, April 15, 2021 /PRNewswire/ — ERT, the global leader in clinical endpoint data collection, today announced new features and functionality for their industry-leading MasterScope TM ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Norwest today announced it has sold iCardiac Technologies to ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials.
PHILADELPHIA, April 15, 2021 /PRNewswire/ — ERT, the global leader in clinical endpoint data collection, today announced new features and functionality for their industry-leading MasterScope TM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results